Intraocular pressure in patients with human immunodeficiency virus and treated with highly active antiretroviral therapy.
OBJECTIVE
To compare the intraocular pressure (IOP) of patients infected with human immunodeficiency virus (HIV) and treated with highly active antiretroviral therapy (HAART) to a control group and to determine whether HAART reverses the previously reported reduction in IOP associated with HIV infection.


METHODS
Retrospective case control study.


METHODS
Review of patients with HIV infection on HAART compared with a matched control group.


RESULTS
Among 64 patients and 56 control subjects, no significant difference in IOP was found (P =.520), nor was correlation noted between IOP and either CD4+ T-lymphocyte counts, or viral load.


CONCLUSIONS
When HIV infection is treated with HAART, IOP is not significantly different from that of control subjects.
Park
Roy J
RJ
Department of Ophthalmology, University of Washington, Seattle, Washington 98195, USA.
Mudumbai
Raghu C
RC
Chen
Philip P
PP
D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D016022:Case-Control Studies; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects* / Q000502:physiology; D008297:Male; D012189:Retrospective Studies
D019380:Anti-HIV Agents